Nektar Presents Late-Breaking Phase 2 Results of NKTR-255 at SITC
07 Nov 2024 //
PR NEWSWIRE
Sibylla Biotech And MD Anderson Announce Strategic Collaboration
12 Jun 2024 //
BUSINESSWIRE
Ori Biotech Partners with the Cell Therapy MFG Center to Accelerate Cell Therapy
13 Sep 2022 //
CONTRACTPHARMA
Virogin Biotech and MD Anderson Announce Strategic Collaboration
08 Sep 2022 //
GLOBENEWSWIRE
No Q2 call yet for Vivos; San Diego biotech collabs with MD Anderson
23 Aug 2022 //
ENDPTS
Erasca and MD Anderson Announce Strategic Research and Development Collaboration in RAS/MAPK-Driven Cancers
23 Aug 2022 //
PRESS RELEASE
Turning Point, MD Anderson Enter Alliance to Advance Precision Cancer Therapies
24 Jun 2022 //
GLOBENEWSWIRE
Invectys, MD Anderson And CTMC Announce Collaboration For Car T Cell Therapy
16 Jun 2022 //
GLOBENEWSWIRE
Resilience forges JV with MD Anderson, readying new cell therapies for cancer
06 Jun 2022 //
ENDPTS
Alpha Tau signs research pact with MD Anderson to study potential of Alpha DaRT
21 Jan 2022 //
PHARMABIZ
Yingli Pharma, MD Anderson Collaborate for Multiple Oncology Programs
20 Jan 2022 //
GLOBENEWSWIRE
Avenge Bio uncloaks with $45M and a slate of immunotherapies
05 Jan 2022 //
ENDPTS
Boosting I-O by targeting a cellular stress pathway
27 Oct 2021 //
FIERCEBIOTECH
Citius to Host Key Opinion Leader Webcast
25 Oct 2021 //
PRNEWSWIRE
Iterion begins phase 1 trial of tegavivint to treat AML
21 Oct 2021 //
PHARMABIZ
MD Anderson & Schrödinger Collaborate to Accelerate Development of WEE1 Program
07 Oct 2021 //
BIOSPACE
OncoNano Medicine Collaborates With UT Southwestern Medical Center for cancer
22 Sep 2021 //
BIOSPACE
Texas Original Cultivation Opens New Prescription Pick-Up North Austin
27 Jul 2021 //
PR NEWSWIRE
Boehringer enlists another virtual biotech for its foray into retinal diseases
20 Sep 2019 //
ENDPTS
4D pharma and MD Anderson Cancer Center to Evaluate Live Biotherapeutics
18 Jan 2019 //
PR NEWSWIRE
Clinical Data for Zymeworks’ Novel Bispecific Antibody, ZW25 at ASCO
01 Jun 2018 //
BUSINESSWIRE
Amgen to ramp up early-stage I-O with 2 MD Anderson deals
31 May 2018 //
FIERCE BIOTECH
AbbVie, MD Anderson in immuno-oncology research deal
22 Jan 2016 //
PHARMATIMES
BI & MD Anderson Cancer Center join forces to discover new treatment
03 Dec 2015 //
PR NEWS WIRE
Research study tests pancreatic cancer drug at Banner MD Anderson Cancer Center
20 Aug 2015 //
PR NEWS WIRE